118 related articles for article (PubMed ID: 16226335)
1. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia.
De Bruyne R; Portmann B; Samyn M; Bansal S; Knisely A; Mieli-Vergani G; Dhawan A
J Hepatol; 2006 Feb; 44(2):407-10. PubMed ID: 16226335
[TBL] [Abstract][Full Text] [Related]
2. 6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.
Ravikumara M; Hill FG; Wilson DC; Gillett PM; Thomas A; Brown R; Darbyshire PJ; McKiernan PJ
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):535-8. PubMed ID: 16707977
[TBL] [Abstract][Full Text] [Related]
3. Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review.
Toksvang LN; Schmidt MS; Arup S; Larsen RH; Frandsen TL; Schmiegelow K; Rank CU
PLoS One; 2019; 14(5):e0212157. PubMed ID: 31125338
[TBL] [Abstract][Full Text] [Related]
4. Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.
Vora A; Mitchell CD; Lennard L; Eden TO; Kinsey SE; Lilleyman J; Richards SM; ;
Lancet; 2006 Oct; 368(9544):1339-48. PubMed ID: 17046466
[TBL] [Abstract][Full Text] [Related]
5. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine.
Erb N; Harms DO; Janka-Schaub G
Cancer Chemother Pharmacol; 1998; 42(4):266-72. PubMed ID: 9744770
[TBL] [Abstract][Full Text] [Related]
7. Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy.
Broxson EH; Dole M; Wong R; Laya BF; Stork L
Pediatr Blood Cancer; 2005 Mar; 44(3):226-31. PubMed ID: 15503293
[TBL] [Abstract][Full Text] [Related]
8. The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.
van Asseldonk DP; Jharap B; Verheij J; den Hartog G; Westerveld DB; Becx MC; Russel MG; Engels LG; de Jong DJ; Witte BI; Mulder CJ; van Nieuwkerk CM; Bloemena E; de Boer NK; van Bodegraven AA
Inflamm Bowel Dis; 2016 Sep; 22(9):2112-20. PubMed ID: 27482972
[TBL] [Abstract][Full Text] [Related]
9. Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency.
McBride KL; Gilchrist GS; Smithson WA; Weinshilboum RM; Szumlanski CL
J Pediatr Hematol Oncol; 2000; 22(5):441-5. PubMed ID: 11037857
[TBL] [Abstract][Full Text] [Related]
10. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia.
Stoneham S; Lennard L; Coen P; Lilleyman J; Saha V
Br J Haematol; 2003 Oct; 123(1):100-2. PubMed ID: 14510948
[TBL] [Abstract][Full Text] [Related]
11. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
Ferlitsch A; Teml A; Reinisch W; Ulbrich G; Wrba F; Homoncik M; Gangl A; Peck-Radosavljevic M; Vogelsang H
Am J Gastroenterol; 2007 Nov; 102(11):2495-503. PubMed ID: 17894846
[TBL] [Abstract][Full Text] [Related]
12. Long-term risk of portal hypertension and related complications in children treated with 6-thioguanine for acute lymphoblastic leukemia: A single-center experience.
Roy Moulik N; M Taj M
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28233441
[TBL] [Abstract][Full Text] [Related]
13. Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations.
Lancaster DL; Lennard L; Rowland K; Vora AJ; Lilleyman JS
Br J Haematol; 1998 Jul; 102(2):439-43. PubMed ID: 9695957
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatotoxicity following 6-thioguanine therapy for childhood acute lymphoblastic leukaemia.
Piel B; Vaidya S; Lancaster D; Taj M; Pritchard-Jones K
Br J Haematol; 2004 May; 125(3):410-1; author reply 412. PubMed ID: 15086428
[No Abstract] [Full Text] [Related]
15. Long-term follow-up of children with 6-thioguanine-related chronic hepatoxicity following treatment for acute lymphoblastic leukaemia.
Rawat D; Gillett PM; Devadason D; Wilson DC; McKiernan PJ
J Pediatr Gastroenterol Nutr; 2011 Nov; 53(5):478-9. PubMed ID: 21701407
[TBL] [Abstract][Full Text] [Related]
16. Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia.
Moon SY; Lim JH; Kim EH; Nam Y; Yu KS; Hong KT; Choi JY; Hong CR; Kim H; Kang HJ; Shin HY; Lee K; Song J; Lee SY; Song SH
Ther Drug Monit; 2019 Feb; 41(1):75-85. PubMed ID: 30507626
[TBL] [Abstract][Full Text] [Related]
17. Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
Jacobs SS; Stork LC; Bostrom BC; Hutchinson R; Holcenberg J; Reaman GH; Erdmann G; Franklin J; Neglia JP; Steinberg SM; Balis FM; Adamson PC; ;
Pediatr Blood Cancer; 2007 Sep; 49(3):250-5. PubMed ID: 16856155
[TBL] [Abstract][Full Text] [Related]
18. A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine.
Seiderer J; Zech CJ; Reinisch W; Lukas M; Diebold J; Wrba F; Teml A; Chalupna P; Stritesky J; Schoenberg SO; Schima W; Göke B; Ochsenkühn T
J Hepatol; 2005 Aug; 43(2):303-9. PubMed ID: 15964660
[TBL] [Abstract][Full Text] [Related]
19. Thioguanine versus mercaptopurine in childhood ALL.
Stanulla M; Schünemann HJ
Lancet; 2006 Oct; 368(9544):1304-6. PubMed ID: 17046444
[No Abstract] [Full Text] [Related]
20. Hepatotoxicity of 6-mercaptopurine in childhood acute lymphocytic leukemia: pharmacokinetic characteristics.
Berkovitch M; Matsui D; Zipursky A; Blanchette VS; Verjee Z; Giesbrecht E; Saunders EF; Evans WE; Koren G
Med Pediatr Oncol; 1996 Feb; 26(2):85-9. PubMed ID: 8531858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
